Biocentury: Regeneron Using Interleukin Antibody Receptors for Asthma Medication

An estimated 25 million Americans suffer from Asthma, but current medications such as inhalers have been deemed ineffective for 10-20% of its users. Regneron (REGN) and Sanofi (SAN) have partnered to crease a new Asthma drug, Dupilumab.

Read more »

Inhalable Drugs Let Patients Take a Breather from Needles

Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.

Read more »

As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181

DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.

Read more »

Researchers Identify Gene Linked to Childhood Asthma

U.S. researchers have identified a gene that is linked to childhood asthma.

Read more »

NeoPharm Tipped As Stock to Watch

NeoPharm, a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha.

Read more »

[Company Profile] Reata Pharmaceuticals

According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood.

Read more »